Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 04 2023
Historique:
received: 18 02 2023
revised: 29 03 2023
accepted: 07 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Syncope is a complex clinical manifestation that presents considerable diagnostic difficulties and, consequently, numerous critical issues regarding fitness for work, especially for high-risk tasks. To date, it is impossible to quantify the exact impact of syncope on work and public safety since it is highly improbable to identify loss of consciousness as the fundamental cause of work or driving-related accidents, especially fatal injuries. Working at high-risk jobs such as public transport operators, in high elevations, or with exposure to moving parts, construction equipment, fireworks, or explosives demand attention and total awareness. Currently, no validated criteria or indicators are available for occupational risk stratification of a patient with reflex syncope to return to work. By drawing inspiration from the updated literature, this narrative review intends to summarise the leading knowledge required regarding the return to work for subjects affected by syncope. According to the available data, the authors highlighted some key findings, summarised in macro-items, such as defined risk stratification for vasovagal accidents, return to work after a critical event, and a focus on pacemaker (PM) implementation. Lastly, the authors proposed a flowchart for occupational physicians to help them manage the cases of workers affected by syncope and exposed to levels of risk that could represent a danger to the workers' health.

Identifiants

pubmed: 37107742
pii: ijerph20085460
doi: 10.3390/ijerph20085460
pmc: PMC10138125
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Europace. 2012 Oct;14(10):1506-14
pubmed: 22588456
Int J Cardiol. 2018 Nov 1;270:149-153
pubmed: 29980368
Eur Heart J. 2021 May 1;42(17):1654-1660
pubmed: 33624801
Clin Auton Res. 2022 Jun;32(3):167-173
pubmed: 35524080
Cardiol Clin. 1997 May;15(2):327-39
pubmed: 9164719
J Cardiovasc Electrophysiol. 2006 Nov;17(11):1172-6
pubmed: 17074006
Am J Cardiol. 2003 Jun 1;91(11):1373-4
pubmed: 12767440
Circulation. 2009 Sep 15;120(11):928-34
pubmed: 19720940
Eur Heart J. 2006 Feb;27(3):344-50
pubmed: 16223744
J Am Coll Cardiol. 2013 Jun 18;61(24):2488-2489
pubmed: 23542111
Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4):
pubmed: 28420655
Arrhythm Electrophysiol Rev. 2021 Dec;10(4):244-249
pubmed: 35106176
J Cardiovasc Electrophysiol. 2006 Sep;17(9):998-1003
pubmed: 16764705
Prog Cardiovasc Dis. 2013 Jan-Feb;55(4):454-63
pubmed: 23472784
Cardiol Rev. 2007 Nov-Dec;15(6):304-9
pubmed: 18090066
Circulation. 2000 Dec 5;102(23):2898-906
pubmed: 11104751
Circulation. 2007 Mar 6;115(9):1170-6
pubmed: 17287391
Auton Neurosci. 2014 Sep;184:46-52
pubmed: 24881013
G Ital Med Lav Ergon. 2011 Jul-Sep;33(3 Suppl):303-5
pubmed: 23393862
J Am Coll Cardiol. 2008 Jan 22;51(3):276-83
pubmed: 18206736
Eur J Intern Med. 2023 Apr;110:41-47
pubmed: 36639324
Europace. 2013 Mar;15(3):388-94
pubmed: 23125355
BMJ. 2003 Jan 4;326(7379):21
pubmed: 12511456
G Ital Cardiol. 1999 May;29(5):533-9
pubmed: 10367221
G Ital Med Lav Ergon. 2004 Apr-Jun;26(2):90-6
pubmed: 15270435
JAMA Intern Med. 2016 Apr;176(4):503-10
pubmed: 26927689
J Am Coll Cardiol. 1998 Mar 1;31(3):608-15
pubmed: 9502643
J Clin Epidemiol. 1991;44(10):1037-43
pubmed: 1940996
Circulation. 1996 Sep 1;94(5):1147-66
pubmed: 8790068
Eur Heart J. 2018 Jun 1;39(21):1883-1948
pubmed: 29562304
Europace. 2013 Aug;15(8):1210-4
pubmed: 23478089
Front Physiol. 2014 Dec 08;5:471
pubmed: 25538626
Europace. 2015 Feb;17(2):300-8
pubmed: 25476868
Europace. 2023 Feb 16;25(2):263-269
pubmed: 36796797
Eur Heart J. 2009 Nov;30(21):2631-71
pubmed: 19713422
Can J Cardiol. 2004 Nov;20(13):1314-20
pubmed: 15565193
Eur Heart J. 2021 Feb 1;42(5):508-516
pubmed: 33279955
Int J Cardiol. 2021 Jul 15;335:52-54
pubmed: 33887343
Am J Emerg Med. 2010 May;28(4):432-9
pubmed: 20466221
Eur Heart J. 2021 Sep 14;42(35):3427-3520
pubmed: 34455430
Heart. 2013 Nov;99(21):1609-13
pubmed: 23723446

Auteurs

Anna Rita Corvino (AR)

Experimental Medicine Department-Hygiene, Occupational, and Forensic Medicine Division-Occupational Forensic Area, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Vincenzo Russo (V)

Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, 80131 Naples, Italy.

Maria Grazia Lourdes Monaco (MGL)

Occupational Medicine Unit, University Hospital of Verona, 37134 Verona, Italy.

Elpidio Maria Garzillo (EM)

Department of Prevention, Abruzzo Local Health Unit No. 1, 67100 L'Aquila, Italy.

Daniele Guida (D)

Experimental Medicine Department-Hygiene, Occupational, and Forensic Medicine Division-Occupational Forensic Area, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Angelo Comune (A)

Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, 80131 Naples, Italy.

Erika Parente (E)

Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, 80131 Naples, Italy.

Monica Lamberti (M)

Experimental Medicine Department-Hygiene, Occupational, and Forensic Medicine Division-Occupational Forensic Area, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Nadia Miraglia (N)

Experimental Medicine Department-Hygiene, Occupational, and Forensic Medicine Division-Occupational Forensic Area, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH